Glenn Sblendorio - Feb 13, 2025 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role
Director
Signature
/s/ Adam Levy, Attorney-in-fact
Stock symbol
MLYS
Transactions as of
Feb 13, 2025
Transactions value $
$0
Form type
4
Date filed
2/24/2025, 06:58 PM
Previous filing
Jun 7, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MLYS Stock Option Award $0 +32.9K $0.00 32.9K Feb 13, 2025 Common Stock 32.9K $10.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in 12 substantially equal monthly installments following the date of grant.